These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33674403)

  • 41. Impact of rigid and nonrigid registration on the determination of 18F-FDG PET-based tumour volume and standardized uptake value in patients with lung cancer.
    Grgic A; Ballek E; Fleckenstein J; Moca N; Kremp S; Schaefer A; Kuhnigk JM; Rübe C; Kirsch CM; Hellwig D
    Eur J Nucl Med Mol Imaging; 2011 May; 38(5):856-64. PubMed ID: 21258929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interim PET in Diffuse Large B-Cell Lymphoma.
    Kurch L; Hüttmann A; Georgi TW; Rekowski J; Sabri O; Schmitz C; Kluge R; Dührsen U; Hasenclever D
    J Nucl Med; 2021 Aug; 62(8):1068-1074. PubMed ID: 33246974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bayesian penalized likelihood PET reconstruction impact on quantitative metrics in diffuse large B-cell lymphoma.
    Young JR; Mugu VK; Johnson GB; Ehman EC; Packard AT; Homb AC; Nathan MA; Thanarajasingam G; Kemp BJ
    Medicine (Baltimore); 2023 Feb; 102(6):e32665. PubMed ID: 36820562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL.
    Mikhaeel NG; Smith D; Dunn JT; Phillips M; Møller H; Fields PA; Wrench D; Barrington SF
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1209-19. PubMed ID: 26902371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of baseline and interim [
    Yadgarov MY; Dunaykin MM; Shestopalov GI; Kailash C; Kireeva ED; Myakova NV; Likar YN
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1955-1964. PubMed ID: 38351389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak.
    Laffon E; Lamare F; de Clermont H; Burger IA; Marthan R
    Eur Radiol; 2014 Aug; 24(8):1964-70. PubMed ID: 24895030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
    Xu W; Yu S; Ma Y; Liu C; Xin J
    Nucl Med Commun; 2017 Mar; 38(3):259-265. PubMed ID: 28118260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does enhanced CT influence the biological GTV measurement on FDG-PET images?
    Vera P; Modzelewski R; Hapdey S; Gouel P; Tilly H; Jardin F; Ruan S; Gardin I
    Radiother Oncol; 2013 Jul; 108(1):86-90. PubMed ID: 23618503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of 18-fluorodeoxyglucose PET/computed tomography parameters and clinical features to predict outcome for diffuse large B-cell lymphoma.
    Baratto L; Wu F; Minamimoto R; Hatami N; Liang T; Sabile J; Advani RH; Mittra E
    Nucl Med Commun; 2021 Jul; 42(7):792-799. PubMed ID: 33741852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [
    Gui J; Li M; Xu J; Zhang X; Mei H; Lan X
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2308-2319. PubMed ID: 38467921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients?
    Enilorac B; Lasnon C; Nganoa C; Fruchart C; Gac AC; Damaj G; Aide N
    J Nucl Med; 2018 Jul; 59(7):1049-1055. PubMed ID: 29242403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-center experience.
    Campiotti L; DE Palma D; Guasti L; Proserpio I; Casagrande S; Schiorlin I; Bolzacchini E; Suter M; Ogliari F; Squizzato A
    Q J Nucl Med Mol Imaging; 2021 Mar; 65(1):59-63. PubMed ID: 30781938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [Formula: see text]F]FDG PET/CT.
    Nikulin P; Zschaeck S; Maus J; Cegla P; Lombardo E; Furth C; Kaźmierska J; Rogasch JMM; Holzgreve A; Albert NL; Ferentinos K; Strouthos I; Hajiyianni M; Marschner SN; Belka C; Landry G; Cholewinski W; Kotzerke J; Hofheinz F; van den Hoff J
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2751-2766. PubMed ID: 37079128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
    Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
    J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.
    Itti E; Lin C; Dupuis J; Paone G; Capacchione D; Rahmouni A; Haioun C; Meignan M
    J Nucl Med; 2009 Apr; 50(4):527-33. PubMed ID: 19289424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
    Duimering A; Riauka T; Nijjar Y; Ghosh S; MacEwan R; Warkentin H; Schiller D; Tankel K; Usmani N; Severin D; Nijjar T; Fairchild A; Mulder K; Doll C; Wong C; Joseph K
    Radiother Oncol; 2019 Jul; 136():21-28. PubMed ID: 31015125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation?
    Campbell BA; Brown R; Lambertini A; Hofman MS; Bressel M; Seymour JF; Wirth A; MacManus M; Dickinson M
    Br J Haematol; 2023 May; 201(3):502-509. PubMed ID: 37015002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of an artificial intelligence-based tool in [
    Sachpekidis C; Enqvist O; Ulén J; Kopp-Schneider A; Pan L; Jauch A; Hajiyianni M; John L; Weinhold N; Sauer S; Goldschmidt H; Edenbrandt L; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3697-3708. PubMed ID: 37493665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.